RankAlpha logo
Back to Rankings

AUPH

AuriniaB
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
View Chart
+
Peers tracked
10
U.S. public peers
Grade Position
In line
vs peer average
AUPH vs peer average
69/100
AUPH vs. peer average (B vs. C)
Grade spread
B 4 · C 2 · D 2 · F 2
Graded peers loaded
Coverage
10 graded
100% of tracked

Peer overview

GILD is the first available peer comparator.

Gilead is a useful commercial-biopharma comp for specialty-drug execution and capital allocation, but it is not a direct lupus nephritis peer, so read-through is limited.

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerGILDGilead Sciences
AUPH
Aurinia
GILD
Gilead Sciences
Grade
B
B
Momentum
46
65
Value
69
66
Sentiment
67
63
Setup Bias
Net —
-
Market Cap
-
-
Posture
Constructive
Constructive

Grade position vs GILD

AUPH / GILD
Grade Position
In line
AUPH vs. peer average (B vs. C)
69/100
Momentum
46
GILD
Value
69
AUPH
Sentiment
67
AUPH

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs AUPH
1
GILD
GILD
B
80/100
Even
2
AMGN
AMGN
D
40/100
+2
3
TSHA
Taysha Gene Therapies Inc Common
C
60/100
+1
4
GENB
Generate Biomedicines Inc Common
B
80/100
Even
5
GHRS
GH Research Plc Common
D
40/100
+2
GILD is the first peer returned for this comparison set.